Scott Koenig is President and CEO of MACROGENICS INC. Currently has a direct ownership of 0 shares of MGNX, which is worth approximately $0. The most recent transaction as insider was on Oct 07, 2024, when has been sold 53,265 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Scott Koenig Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 07 2024
SELL
Bona fide gift
-
53,265 Reduced 100.0%
0 Common Stock
Sep 23 2024
SELL
Bona fide gift
-
374,215 Reduced 34.73%
703,413 Common Stock
Feb 15 2024
SELL
Payment of exercise price or tax liability
$249,672 $17.4 p/Share
14,349 Reduced 1.31%
1,077,628 Common Stock
Feb 15 2024
BUY
Exercise of conversion of derivative security
-
42,341 Added 3.73%
1,091,977 Common Stock
May 16 2022
BUY
Exercise of conversion of derivative security
$80,430 $1.51 p/Share
53,265 Added 4.83%
1,049,636 Common Stock

Also insider at

AGTC
APPLIED GENETIC TECHNOLOGIES CORP Healthcare
GLYC
GLYCOMIMETICS INC Healthcare
SK

Scott Koenig

President and CEO
Alachua, FL

Track Institutional and Insider Activities on MGNX

Follow MACROGENICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MGNX shares.

Notify only if

Insider Trading

Get notified when an Macrogenics Inc insider buys or sells MGNX shares.

Notify only if

News

Receive news related to MACROGENICS INC

Track Activities on MGNX